JP Morgan Chase
PROK icon

JP Morgan Chase’s ProKidney PROK Stock Holding History

JP Morgan Chase’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7K Buy
32,125
+31,369
+4,149% +$57.4K ﹤0.01% 6349
2026
Q1 		$1.23K Hold
756
– – ﹤0.01% 7095
2025
Q4 		$1.69K Hold
756
– – ﹤0.01% 6968
2025
Q3 		$1.83K Sell
756
-1,667,886
-100% -$4.44M ﹤0.01% 6932
2025
Q2 		$988K Buy
1,668,642
+1,615,243
+3,025% +$1.26M ﹤0.01% 4387
2025
Q1 		$46.8K Sell
53,399
-13,016
-20% -$18.1K ﹤0.01% 5905
2024
Q4 		$112K Buy
66,415
+19,585
+42% +$35.3K ﹤0.01% 5709
2024
Q3 		$89.9K Buy
46,830
+18,472
+65% +$41.9K ﹤0.01% 5744
2024
Q2 		$69.8K Buy
28,358
+7,546
+36% +$20.3K ﹤0.01% 5712
2024
Q1 		$34.1K Sell
20,812
-9,252
-31% -$13.6K ﹤0.01% 6075
2023
Q4 		$53.5K Buy
30,064
+133
+0.4% +$285 ﹤0.01% 5976
2023
Q3 		$137K Sell
29,931
-18,076
-38% -$173K ﹤0.01% 5298
2023
Q2 		$537K Buy
48,007
+43,725
+1,021% +$465K ﹤0.01% 4440
2023
Q1 		$49K Buy
4,282
+915
+27% +$9.74K ﹤0.01% 5708
2022
Q4 		$23K Buy
+3,367
New +$32.2K ﹤0.01% 5844
2022
Q3 		– Sell
-100,000
Closed -$995K – 6769
2022
Q2 		$995K Sell
100,000
-310,356
-76% -$3.07M ﹤0.01% 4082
2022
Q1 		$4.06M Buy
+410,356
New +$4.05M ﹤0.01% 3181
2021
Q4 		– Sell
-150,000
Closed -$1.47M – 6895
2021
Q3 		$1.47M Buy
150,000
+55,300
+58% +$545K ﹤0.01% 4021
2021
Q2 		$959K Buy
+94,700
New +$957K ﹤0.01% 4325

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase's PROK Position: Q2 2026 in Review

JP Morgan Chase increased its ProKidney (PROK) stake by 4,149% in Q2 2026, buying an estimated $57.4K and bringing the position to 32,125 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6349.

JP Morgan Chase first reported a position in PROK in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.06M in Q1 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • JP Morgan Chase held 32,125 shares of ProKidney worth $60.7K as of Q2 2026.
  • JP Morgan Chase bought 31,369 ProKidney shares in Q2 2026, an estimated $57.4K.
  • ProKidney made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6349 holding.
  • JP Morgan Chase first reported a position in ProKidney in Q2 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's ProKidney position peaked at $4.06M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.